From The Industry Experts

  1. What's Wrong With Site Benchmarking? A Site-Centered Perspective On Its Alignment, Transparency, And Use 6/9/2026

    Benchmarking is widely used and highly valued, yet trust in it is limited. The League Benchmarking Working Group has set out to standardize how site metrics are defined, contextualized, and applied.

  2. New Primary Endpoint For Tetraplegia Drug Gets Support From Patients And The FDA 6/9/2026

    NervGen CEO Adam Rogers discussed why choosing a hand function endpoint for tetraplegia made sense for patients and how regulators helped guide and support the company's decision.

  3. The FDA Could Clear The Path For A Strep A Vaccine. Why Hasn't It? 6/8/2026

    Strep A kills around 500,000 people each year, and a vaccine would change this and is within reach. Yet, no strep A vaccine is currently in Phase 3. 1Day Sooner's Josh Morrison explains why and shares how FDA could make Strep A vaccines a reality.

  4. Anthropic's Stainless Acquisition: What It Means For Clinical Trials 6/5/2026

    As AI models become interchangeable, value is shifting to the orchestration layer that connects tools, workflows, and governance—making flexibility, interoperability, and auditability critical.

  5. How Acquiring Sponsors Can Keep Post-Acquisition Clinical Operations Running Smoothly 6/5/2026

    When acquiring another company, the acquiring sponsor must preserve operational continuity across active trials while integrating new assets, teams, technologies, vendors, and decision structures. Leila Cupersmith explains how.

  6. How AI Is Reshaping RTSM Study Builds 6/4/2026

    How Agentic RTSM cuts study build timelines by up to 80%, accelerating kickoff-to-UAT while maintaining compliance, quality, and auditability in clinical trials.

  7. Selecting The Right Site Payments Solution For Today's Clinical Trials: What To Look For 6/4/2026

    Are you managing site payments with spreadsheets and manual processes? Discover how automation can reduce administrative burden, improve site relationships, and accelerate clinical trial operations.

  8. Don't Just Swap The Engine. Redesign The Factory. 6/4/2026

    Discover how AI-native technology is accelerating study startup, streamlining operations, and helping sponsors and CROs deliver therapies to patients faster.

  9. Successful SwissMedic Marketing Authorization Application For An Oncology Therapy 6/4/2026

    See how strategic EU dossier adaptation and Swiss-specific regulatory expertise enabled a successful SwissMedic submission and accelerated market access for an oncology therapy.

  10. End-To-End Clinical, Biometrics, And Regulatory Support In Neurology 6/4/2026

    Discover how an integrated NDA strategy aligned data, vendors, and regulatory execution to achieve an on-time submission and approval without major FDA queries.